ArticleF1000Research2025

Optimizing Cardiovascular Treatment in Non-Small Cell Lung Cancer: A Comprehensive Computational Approach for Assessment of Drug-Drug Interactions Between Tyrosine Kinase Inhibitors and Cardiovascular Drugs.

Prajakta Patil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.